The unique history of Wilson Sonsini Goodrich & Rosati closely traces the birth and evolution of Silicon Valley.
For more than 60 years, Wilson Sonsini has represented technology pioneers associated with virtually every milestone innovation, as well as life sciences trailblazers shaping the future of healthcare.
Today, the firm is synonymous with ushering promising, innovative companies through their business life cycle.
Careers
We look for the best and brightest of tomorrow and develop careers from the ground up.
News and Featured Insights
Press Releases
Client Advisories
Leading Matters
Client Highlights
Wilson Sonsini Advises Circle Games on $25 Million Series A
On September 24, 2026, Istanbul-based mobile game studio Circle Games announced it raised $25 million in a Series A round led by Tencent, taking its total investment to $32.25 million. Existing investors e2vc, BITKRAFT Ventures, APY Ventures, and a16z Speedrun also participated in the round. Wilson Sonsini Goodrich & Rosati advised Circle Games on the transaction.
Client Highlights
Wilson Sonsini Advises BlackLine on Acquisition of NetNow
On September 21, 2026, BlackLine, the future-ready platform for the office of the chief financial officer that drives digital finance transformation by empowering organizations with accurate, efficient, and intelligent financial operations, announced it has acquired NetNow, an AI-enabled B2B customer onboarding and credit risk management solution. The acquisition expands BlackLine's invoice-to-cash capabilities, bringing automated credit intelligence, AI-enabled risk and fraud detection, and ongoing portfolio monitoring, further upstream in the customer financial lifecycle. Wilson Sonsini Goodrich & Rosati advised BlackLine on the transaction.
Client Highlights
Wilson Sonsini Advises Ferry Health on $9 Million Fundraise as Company Emerges from Stealth
On September 16, 2026, Ferry Health, an agentic artificial intelligence (AI) platform supporting patients in administrative tasks, launched out of stealth, raising $9 million in seed funding from Andreessen Horowitz (a16z), Index Ventures, Avid Ventures, Layout Ventures, SV Angel, Box Group, and Asymmetric Capital, as well as Jay Desai and the founders of Grow Therapy, Hex, and Chapter. Wilson Sonsini Goodrich & Rosati advised Ferry on the fundraising transactions.
Client Highlights
Firm Advises Ayble Health on $16 Million Series A
On September 16, 2026, Ayble Health, the nation's leading AI-enabled virtual multidisciplinary GI clinic, announced the close of a $16 million oversubscribed Series A round led by Neon, with participation from Unum Ventures, Upfront Ventures, M13, Cleveland Clinic Ventures, DigiTx, Accomplice, and several individual strategic investors. The round brings Ayble's total capital raised to over $27 million. Wilson Sonsini Goodrich & Rosati advised Ayble on the transaction.
Client Highlights
Wilson Sonsini Advises Snorkel AI on $350 Million Series E
On September 22, 2026, Snorkel AI, the frontier AI data lab, announced it raised $350 million at a valuation of $3.5 billion. The investment will expand Snorkel AI's agentic data factory, which supplies the data and environments behind the world's most advanced AI lab systems. A Wilson Sonsini Goodrich & Rosati team led by Rezwan Pavri and Bryan King advised Snorkel AI on the transaction.
Client Highlights
Wilson Sonsini Advises The Horowitz Andreessen Academy on $42 Million Funding
On September 22, 2026, a16z announced the launch of The Horowitz Andreessen Academy (The Academy), a highly selective school in San Francisco for the most ambitious young builders after high school—giving them the skills, network, and real-world experiences to excel in a world being fundamentally reshaped by AI. The Academy raised $42 million in funding led by a16z, along with a group of angel investors including Adam D'Angelo (co-founder, Quora), Tobi Lütke (CEO, Shopify), Tony Xu (CEO, DoorDash), Fidji Simo (recently CEO of Applications, OpenAI), Garry Tan (CEO, Y Combinator), Joe Liemandt (Principal, Alpha School), and Shyam Sankar (CTO, Palantir). Wilson Sonsini Goodrich & Rosati advised The Academy on its financing round.
The Life Sciences Report – June 2026
This latest edition features articles on accelerating new therapies under the new FDA administration, cash-pay healthcare companies possibly facing kickback and fee-splitting risk under federal and state laws, building in-house legal teams for biotech, digital health, and medical devices companies, and life sciences venture financings for firm clients across 1H2025.